Evidence map›Paper›PMID 39811937›Full record

ArticleThe Journal of organic chemistry2025

HOMAc: A Parameterization of the Harmonic Oscillator Model of Aromaticity (HOMA) That Includes Antiaromaticity.

Enrique M Arpa, Sven Stafström, Bo Durbeej

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Twisted 1- and 2-Azaperopyrenes: Synthesis, Structure, and Properties.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. On the aromaticity and photophysics of 1-arylbenzo[Beilstein journal of organic chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Enrique M ArpaDivision of Theoretical Chemistry, IFM, Linköping University, 58183 Linköping, Sweden.ORCID 0000-0003-1288-6059
Sven StafströmDivision of Theoretical Physics, IFM, Linköping University, 58183 Linköping, Sweden.
Bo DurbeejDivision of Theoretical Chemistry, IFM, Linköping University, 58183 Linköping, Sweden.ORCID 0000-0001-5847-1196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The harmonic oscillator model of aromaticity (HOMA) offers a straightforward route to quantifying aromaticity that requires no other information than the bond lengths of the conjugated ring in question. Given that such information is often readily obtainable from quantum-chemical calculations, it is pertinent to improve this parametrized model as much as possible. Here, a new version of HOMA is presented where, atypically, the corresponding parameters are derived from the actual bond lengths of both aromatic and antiaromatic (rather than nonaromatic) reference compounds, as calculated with a high-level method. The resulting model, which we denote HOMAc, covers CC, CN, NN, and CO bonds and is tested at eight different levels of theory for 45 (single-ring, multi-ring, carbocyclic, N,O-heterocyclic) molecules across the aromatic-antiaromatic spectrum. Thereby, it is found that HOMAc provides a description of aromaticity and antiaromaticity in better accord with magnetic, energetic, and π-delocalization-based reference data than does the standard parametrization of HOMA. Altogether, the results highlight the possibility to realize more reliable geometry-based probing of (anti)aromaticity with the use of HOMAc and with substantial freedom in the choice of quantum-chemical method.

Identifiers

PMID39811937
PMCPMC11773415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.